3IKG
Structure-Based Design of Novel PIN1 Inhibitors (I)
3IKG の概要
| エントリーDOI | 10.2210/pdb3ikg/pdb |
| 関連するPDBエントリー | 3I6C 3IK8 3IKD |
| 分子名称 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1, (2R)-2-[(1-benzothiophen-2-ylcarbonyl)amino]-3-(3-methylphenyl)propyl phosphate (3 entities in total) |
| 機能のキーワード | sbdd, ppiase, cell cycle, isomerase, small molecule, nucleus, phosphoprotein, rotamase, peptidyl-prolyl cis-trans isomerase |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Nucleus : Q13526 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 28131.17 |
| 構造登録者 | Parge, H.,Ferre, R.A.,Greasley, S.,Matthews, D. (登録日: 2009-08-05, 公開日: 2009-09-22, 最終更新日: 2023-09-06) |
| 主引用文献 | Guo, C.,Hou, X.,Dong, L.,Dagostino, E.,Greasley, S.,Ferre, R.,Marakovits, J.,Johnson, M.C.,Matthews, D.,Mroczkowski, B.,Parge, H.,Vanarsdale, T.,Popoff, I.,Piraino, J.,Margosiak, S.,Thomson, J.,Los, G.,Murray, B.W. Structure-based design of novel human Pin1 inhibitors (I). Bioorg.Med.Chem.Lett., 19:5613-5616, 2009 Cited by PubMed Abstract: Pin1 is a member of the cis-trans peptidyl-prolyl isomerase family with potential anti-cancer therapeutic value. Here we report structure-based de novo design and optimization of novel Pin1 inhibitors. Without a viable lead from internal screenings, we designed a series of novel Pin1 inhibitors by interrogating and exploring a protein crystal structure of Pin1. The ligand efficiency of the initial concept molecule was optimized with integrated SBDD and parallel chemistry approaches, resulting in a more attractive lead series. PubMed: 19729306DOI: 10.1016/j.bmcl.2009.08.034 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.86 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






